Veralto Other Income (Expense) increased by 333.3% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 216.7%, from -$6.00M to $7.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 10.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.50M | $1.50M | $1.50M | $0.00 | $1.00M | $0.00 | -$14.00M | $0.00 | $0.00 | -$15.00M | $1.00M | $5.00M | $0.00 | -$6.00M | $0.00 | $1.00M | -$3.00M | $7.00M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | -100.0% | — | +100.0% | — | — | +106.7% | +400.0% | -100.0% | — | +100.0% | — | -400.0% | +333.3% |
| YoY Change | — | — | — | -100.0% | -33.3% | — | — | — | -100.0% | — | +107.1% | — | — | +60.0% | -100.0% | -80.0% | — | +216.7% |